- Home
- OCC vs NERV Comparison
OCC vs NERV Comparison
Compare OCC & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- NERV
- Stock Information
- Founded
- OCC 1983
- NERV 2007
- Country
- OCC United States
- NERV United States
- Employees
- OCC N/A
- NERV N/A
- Industry
- OCC Telecommunications Equipment
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- NERV Health Care
- Exchange
- OCC Nasdaq
- NERV Nasdaq
- Market Cap
- OCC 21.8M
- NERV 18.3M
- IPO Year
- OCC 1996
- NERV 2014
- Fundamental
- Price
- OCC $2.55
- NERV $2.62
- Analyst Decision
- OCC
- NERV Hold
- Analyst Count
- OCC 0
- NERV 1
- Target Price
- OCC N/A
- NERV $5.00
- AVG Volume (30 Days)
- OCC 9.4K
- NERV 12.0K
- Earning Date
- OCC 09-11-2024
- NERV 11-05-2024
- Dividend Yield
- OCC N/A
- NERV N/A
- EPS Growth
- OCC N/A
- NERV N/A
- EPS
- OCC N/A
- NERV N/A
- Revenue
- OCC $64,517,697.00
- NERV N/A
- Revenue This Year
- OCC N/A
- NERV N/A
- Revenue Next Year
- OCC N/A
- NERV N/A
- P/E Ratio
- OCC N/A
- NERV N/A
- Revenue Growth
- OCC N/A
- NERV N/A
- 52 Week Low
- OCC $2.43
- NERV $2.26
- 52 Week High
- OCC $3.53
- NERV $13.49
- Technical
- Relative Strength Index (RSI)
- OCC 45.30
- NERV 44.93
- Support Level
- OCC $2.43
- NERV $2.56
- Resistance Level
- OCC $2.75
- NERV $2.72
- Average True Range (ATR)
- OCC 0.09
- NERV 0.11
- MACD
- OCC -0.00
- NERV 0.00
- Stochastic Oscillator
- OCC 37.50
- NERV 30.38
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, broadcast, oil & gas, and others.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.